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Chapter 1 
 
1.1 GENERAL INTRODUCTION 
              Medicinal plants are considered as rich resources of ingredients which can be 
used in drug development and synthesis of medicines. Plants play a vital role in the 
development of human cultures around the whole world. Moreover, some plants 
consider as important source of nutrition and as a result of that plants recommended for 
their therapeutic values.  
 Today the term “Alternative Medicine” became very common in western culture, it 
focus on the idea of using the plants for medicinal purpose. But the current belief that 
medicines which come in capsules or pills are the only medicines that we can trust and 
use. Even so, most of these pills and capsules we take and use during our daily life 
came from plants. Medicinal plants frequently used as raw materials for extraction of 
active ingredients which used in the synthesis of different drugs. Like in case of 
laxatives, blood thinners, antibiotics, and anti-malaria medications contain ingredients 
from plants. Moreover the active ingredients of Taxol, vincristine, and morphine isolated 
from foxglove, vinca and opium poppy, respectively. 
Medicinal plants have a promising future because there are about half million 
plants around the world, and most of them their medical activities have not investigate 
yet, and their medical activities could be decisive in the treatment of future studies. [1] 
 
Herbs are staging a comeback and herbal „renaissance‟ is happening all over the 
globe. The herbal products today symbolize safety in contrast to the synthetics that are 
regarded as unsafe to human and environment. Although herbs had been priced for 
their medicinal, flavoring and aromatic qualities for centuries, the synthetic products of 
the modern age surpassed their importance, for a while. However, the blind 
dependence on synthetics is over and people are returning to the naturals with hope of 
safety and security. Over three-quarters of the world population relies mainly on plants 
and plant extracts for health care. More than 30% of the entire plant species, at one 
time or other was used for medicinal purposes. [2] 
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Chapter 2 
 REVIEW OF LITERATURE 
2.1. General 
Since the beginning of human civilization, medicinal plants have been used by 
mankind for its therapeutic value. Nature has been a source of medicinal agents for 
thousands of years and an impressive number of modern drugs have been isolated 
from natural sources. Many of these isolations were based on the uses of the agents in 
traditional medicine. The plant-based, traditional medicine systems continue to play an 
essential role in health care, with about 80% of the world‟s inhabitants relying mainly on 
traditional medicines for their primary health care. India has several traditional medical 
systems, such as Ayurveda and Unani, which has survived through more than 3000 
years, mainly using plant-based drugs. The materia medica of these systems contains a 
rich heritage of indigenous herbal practices that have helped to sustain the health of 
most rural people of India. The ancient texts like Rig Veda (4500-1600 BC) and Atharva, 
Veda mention the use of several plants as medicine. In addition to their natural role, 
plant secondary metabolites also represent a vast resource of complex molecules that 
are valued and exploited by man for their pharmacological and other properties (Table 
2.1) 
Table 2.1: Some examples of plants as source of drugs.[3] 
 
Plants Part used Uses 
Atropa belladonna Whole plant Sedative 
Adhatoda zeylanicaMedicus. Leaf Asthma, Cold 
Aloe vera Linn. Leaf Wound healing 
Betel piperL. Leaf Pimples 
Cardiospermum canescens Wall. Leaf Dysentery 
Cassia fistula Linn. Leaf Laxative 
Erythrina indica Lam. Leaf Menstrual problem 
Eucalyptus globules Labill. Leaf Body ache, Re-freshener 
Euphorbia anticaram L. Latex Edema 
Ficus bengalensis L. Latex Wound healing 
Lawsonia inermis L. Leaf Heeling crack 
Ocimum santum L. Leaf Dry cough 
Phyllanthus amarus Schum. Leaf Jaundice 
Quercus infectoria Seed husk Wound ,Anti-inflammatory 
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In India, the ayurvedic system has described a large number of such medicines 
based on plants or plant product and the determination of their morphological and 
pharmacological or pharmacognostic characters can provide a better understanding of 
their active principles and mode of action. However, a large number of tropical plants 
have not been studied in detail for their chemical constituents, pharmacological 
properties of the extracts, and their pharmacognostic characterization including DNA 
sequencing etc. In the present review focused various aspects in selected medicinal 
plant Dipteracanthus patulus (Jacq) 
2.2 SELECTION OF PLANT FOR STUDIES  
Dipteracanthus patulus (Jacq) commonly known as kiranti nayan is widely used in 
traditional medicine in India. Extracts of root, leaves, and stem of this plant are widely 
used in the treatment of   Snake bite, wounds, scabies, anti-inflammatory, and ulcers. 
 
2.2.1Plants preferred for present study: 
Sl. 
No. 
Botanical Name of the 
Plant Family Part selected 
01 Dipteracanthus patulus (Jacq) Acanthaceae Leaves 
 
2.2.2 MORPHOLOGY of plant 
Botanical Name                          : Dipteracanthus patulus 
 
Kingdom             : Plantae 
 
Division              : Tracheophyta 
 
Class                                             : Magnoliopsida 
 
Genus                                     : Dipteracanthus 
 
Species               : patulus 
 
Family                : Acanthaceae 
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            Dipteracanthus patulus 
 
 
 
Vernacular Names:  
Tamil    :      Kiranti nayan 
Malayalam      :      Velipadakkam, Thuppalampotti 
English   :      Bell weed 
 
2.2.3 DESCRIPTION OF PLANT: 
Dipteracanthus patulus (Jacq) Undershrub, up to 50 high; branchlets 4-angled, 
pubescent. Leaves opposite, ovate-elliptic, 1.5 - 5 x 1.2 - 3 cm, cuneate-truncate at 
base, entire at margin, acute at apex, densely pubescent; 4 - 5-pairs; petiole up to 1.8 
cm long. Flowers ca. 2.5 cm across, pale blue or violet, solitary, axillary, 2 - 3-flowered; 
bracteole spatulate-elliptic, ca. 1 cm long, obtuse at apex. Calyx - lobes 5, equal, linear-
subulate to lanceolate, 03 mm long, ciliate at margin. Corolla campanulate-
infundibuliform, lobe 5, subs orbicular-ovate, ca. 08 mm long. Ovary oblong-elliptic,   ca. 
02 mm long;   1-loculed; ovules ca. 6; style filiform, 03 mm long, white hairy;   stigma 
subglobose. Capsules    clavate – elliptic to cylindrical up to 1.8 cm long, glabrous; 
seeds ca. 10, orbicular, ca. 03 mm long. The plant   was distributed widely in Pune, 
Satara,thane, Chikmagalur, Dharwar, Mysore, Idukki, Kannur, Kollam, 
Thiruvananthapuram,     Tamil nadu in all districts. 
    
                                                                                                             Arulmigu Kalasalingam College of Pharmacy 
 
D e p a r t m e n t  o f  P h a r m a c o l o g y                                            5 
  
Some vernacular names in India:   
            cilantanceti,  cilantinayakam,  cukkulam,  cuntuilicceti,  cuntumam,  cuntuyili,  
icaimuti,  kakapicam,  kakapikanayacceti,  kattunayakacceti,  kattunayakam,  kiranti, 
kiranti  nayakam,  kirantinayakan, kirantippuntu,  nittinaviral,  nittinaviralkurittan,  
punkiranti,  punkiranticceti,  putakilam,  putakilanceti,  turuputpam,  nayakam, upu-dali, 
vaikkirantitacceti, vaikkirantitam.[4] 
Constituents 
 The major phytoconstituents found in Dipteracanthus patulus   are the Tannis, 
saponins, alkaloids, steroids anthroquinones, tri-terpenoids, and flavonoids. Two lignan 
glycosides,5,5‟-dimethoxylariciresinol-9‟-O- β-D-glucopyranoside and lyoniresinol–9‟-O-β–
D- glucopyranoside were isolated from the extracts of whole plant of Dipteracanthus 
patulus.[5] 
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2.3 PEPTIC ULCER: 
 Peptic ulcer disease is a chronic pathology that affects millions of people 
worldwide. It is believed that 10% of the population will develop this condition at some 
point in their lives. Peptic ulcers are usually classified by their anatomic location, such 
as gastric or duodenal ulcers, and increased gastric acid is the main cause. There is a 
strong association between H. pylori infection and duodenal ulcers. H. pylori causes an 
inflammatory response in the gastric mucosa, with increased production of cytokines 
and influx of neutrophils and macrophages into the gastric mucosa with release of 
leukotrienes (LT) and reactive oxygen species, which makes the defense of the mucosa 
and stimulates ulcer formation process. The disease process of peptic ulcers is 
multifactorial based on etiology and risk factors. Ulcers result from an imbalance 
between aggressive factors, including hydrochloric acid; Helicobacter pylori infection; 
excessive intake of anti-inflammatory drugs, alcohol, pepsin, and reactive oxygen 
species; and cytoprotective factors, which include mucus, bicarbonate, prostaglandins, 
blood flow, and cellular repair, as well as enzymatic and non-enzymatic antioxidants. 
Currently, the goals of treatment of peptic ulcer are based on pain relief, heal the ulcer 
and prevent recurrence of the ulcer.Thus, gastric ulcer treatment options include 
antacids (aluminum hydroxide and magnesium trisilicate), cytoprotective agents 
(sucralfate and the prostaglandin analogue misoprostol), muscarinic antagonists 
(pirenzepine), antimicrobial agents for eradication of H. pylori (amoxicillin and 
clarithromycin), H2 receptor antagonists (cimetidine and ranitidine), and proton pump 
inhibitors (omeprazole and lansoprazole). Many adverse effects are associated with the 
prolonged use of H2 receptor blockers and proton pump inhibitors: hypersensitivity, 
arrhythmia, impotence, gynecomastia, and hypomagnesemia. Moreover, some of these 
treatments are expensive.[6] 
2.3.1 NSAID-induced ulcer: 
A small but important percentage of patients have adverse gastrointestinal 
events associated with NSAID use that results in substantial morbidity and mortality. 
Risk factors for the development of NSAID-associated gastric and duodenal ulcers 
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include advanced age, history of previous ulcer disease, concomitant use of 
corticosteroids and anticoagulants, higher doses of NSAIDs, and serious systemic 
disorders. The concept of gastro duodenal mucosal injury has evolved from the notion 
of topical injury to concepts that involve multiple mechanisms. 
NSAIDs initiate mucosal injury topically by their acidic properties. By diminishing 
the hydrophobicity of gastric mucus, endogenous gastric acid and pepsin may injure 
surface epithelium. Systemic effects of NSAIDs appear to play a predominant role 
through the decreased synthesis of mucosal prostaglandins. The precursor of 
prostaglandins, arachidonic acid, is catalyzed by the two cyclooxygenase isoenzymes, 
cyclo-oxygenase-1 and cyclo-oxygenase-2. The gene for cyclo-oxygenase-1, the 
housekeeping enzyme, maintains the homeostasis of organs. Cyclo-oxygenase-2, the 
inflammatory enzyme, is inducible. Although NSAIDs can inhibit both pathways, only the 
gene for cyclo-oxygenase-2 contains a corticosteroid-responsive repressor element. 
Literature suggests that the anti-inflammatory properties of NSAIDs are mediated 
through inhibition of cyclo-oxgenase-2, and adverse effects, such as gastric and 
duodenal ulceration, occur as a result of effects on the constitutively expressed cyclo-
oxygenase-1. H. pylori is prevalent among 22–63% of patients taking NSAIDs. Most 
studies do not show a significant difference in H. pylori prevalence between NSAID 
users and nonusers. Gastritis in patients on NSAID therapy appears to be related to 
underlying H. pylori rather than drug use. The lower incidence of H. pylori among 
patients with gastric ulcers than those with duodenal ulcers is presumably the result of 
NSAID use. NSAIDs are more likely to cause gastric than duodenal ulcers. NSAID 
appear to cause ulcers by a mechanism independent of H. pylori based on the inhibition 
of prostaglandin synthesis. 
 
2.3.2 GASTRINOMA (Zollinger-Ellison Syndrome): 
The classic triad of Zollinger-Ellison syndrome involves peptic ulcers in unusual 
locations (i.e., the jejunum), massive gastric acid hypersecretion, and a gastrin-
producing islet cell tumor of the pancreas (gastrinoma).  
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2.3.3 ALCOHOL AND DIET-INDUCED ULCER: 
Although alcohol has been shown to induce damage to the gastric mucosa, it 
seems to be related to the absolute ethanol administered (200 proof). Pure ethanol is 
lipid soluble and results in frank, acute mucosal damage. Because most humans do not 
drink absolute ethanol, it is unlikely there is mucosal injury at ethanol concentrations of 
less than 10% (20 proof). Ethanol at low concentrations (5%) may modestly stimulate 
gastric acid secretions; higher concentrations diminish acid secretion. Though 
physiologically interesting, this has no direct link to ulcerogenic or therapy. Some types 
of food and beverages are reported to cause dyspepsia. There is no convincing 
evidence that indicates any specific diet causes ulcer disease. Epidemiologic studies 
have failed to reveal a correlation between caffeinated, decaffeinated, or cola-type 
beverages, beer, or milk with an increased risk of ulcer disease. Dietary alteration, other 
than avoidance of pain-causing foods, is unnecessary in ulcer patients.[7] 
 
2.3.4 STRESS INDUCED ULCER: 
Stress-related mucosal damage (SRMD) is the broad term used to describe the 
spectrum of pathology attributed to the acute, erosive, inflammatory insult to the upper 
gastrointestinal tract associated with critical illness. SRMD represents a continuum from 
asymptomatic superficial lesions found incidentally during endoscopy, occult 
gastrointestinal bleeding causing anemia, overt gastrointestinal bleeding and clinically 
significant gastrointestinal bleeding.[8] 
Stress ulceration was first described in 1969 when focal lesions in the mucosa of 
the gastric fundus were reported during post-mortem examinations in 7 (out of 150) 
critically ill patients.[9] 
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2.4 WOUND HEALING: 
wound healing is a complex and dynamic process, with the wound environment 
changing with the shifting health status of an individual. Knowledge of the physiology of 
the normal wound healing trajectory through the phases of hemostasis, inflammation, 
granulation and maturation provides a framework for understanding the basic principles 
of wound healing. Through this understanding, the health care professional can develop 
the skills required to care for a wound and the patient can be helped with the complex 
task of tissue repair. 
 
2.4.1 PHASES OFWOUND HEALING: 
Wounds also undergo 4 basic phases of healing  
These are: 
• Hemostasis, 
• Inflammation, 
• Proliferation (also known as granulation and contraction), and 
• Remodelling (also known as maturation). 
 
2.4.1 HEMOSTASIS: 
Once the source of damage to a house has been removed and before work can 
start, utility workers must cap damaged gas or water lines. So, too in wound healing 
must damage blood vessels be sealed.  In wound healing, the platelets are the cells that 
act as utility workers sealing off the damaged blood vessels. The blood vessels 
themselves constrict   in response to injury, but this spasm ultimately relaxes. The 
platelets secrete vasoconstrictive substances to aid this process, but their prime role is 
to form a stable clot sealing the damaged vessel. Under the influence   of   ADP 
(adenosine diphosphate) leaking from damaged tissues. 
 
2.4.2 INFLAMMATION: 
Clinically, inflammation (the second stage of wound healing) presents as 
erythema, swelling and warmth often associated with pain, the classic “rubor et tumor 
cum calore et dolore.” This stage usually lasts up to 4 days post injury. In the damaged 
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house analogy, once the utilities are capped the second job is to clean up the debris. 
This is a job for unskilled labourers. In a wound, these unskilled labourers are the 
neutrophils (polymorphonucleocytes). The inflammatory response causes the blood 
vessels to become leaky, releasing plasma and neutrophils into the surrounding tissue. 
The neutrophils phagocytose debris and microorganisms and provide the first line of 
defence against infection. 
2.4.3 PROLIFERATION:  
 The proliferation phase starts approximately 4 days after wounding and usually 
lasts until day 21 in acute wounds, depending on the size of the wound and the health 
of the patient. It is characterized by angiogenesis, collagen deposition, granulation 
tissue formation, wound contraction and epithelialization. Clinically, proliferation is 
observed by the presence of pebbled red tissue or collagen in the wound base and 
involves replacement of dermal tissues and sometimes subdermal tissues in deeper 
wounds, as well as contraction of the wound. 
2.4.4 REMODELLING: 
Once the basic structure of the house is completed, interior finishing may begin. 
Similarly, in wound repair, the healing process involves remodelling and realignment of 
the collagen tissue to produce greater tensile strength. In addition, cell and capillary 
density decrease. The main cells involved in this process are the fibroblasts. 
Remodelling can take up to 2 years after wounding.[10] 
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2.5 Review of various literature: 
Saroja, et al.,   2009wounds are physical injuries that result in an opening or 
break of the skin. Proper healing of wounds is essential for the restoration of disrupted 
anatomical continuity and disturbed functional status of the skin. Current estimates 
indicate that nearly 6 million people suffer from chronic wounds worldwide. Community-
based epidemiological study of wounds in India revealed the prevalence of acute and 
chronic wounds as 10.55 and 4.48 per 1000 population respectively. Healing of chronic 
lower extremity wounds is a global problem. Research on wound healing agents is one 
of the developing areas in modern biomedical sciences. Many traditional practitioners 
across the world particularly in countries like India and China with age old traditional 
practices have valuable information of many lesser-known either to unknown wild plants 
used for treating wounds and burns Some of these plants have been screened 
scientifically for the evaluation of their wound healing activity in different 
pharmacological models but the potential of most of the plants remain unexplored.  
Dipteracanthus patulus (Jacq.)Nees. (Syn. Ruellia patula Jacq).(Acanthaceae) 
commonly known as Kiranthinayagam or Kayappacchilai in Tamil is a medicinal herb 
traditionally used in the treatment of.  Wounds in the rural areas. The leaves are ground 
into a paste and applied on fresh wounds. The plant is commonly distributed on 
wastelands in Tamil Nadu. The leaves are used for treating itches, insect bites, 
paranychia, venereal diseases, sores, tumours, rheumatic complaints and eye diseases 
. Pharmacological and phytochemical studies indicated that it is a cardiotonic.[11] 
 
 Yadav, Sanjay, et al., 2012 to screen and evaluate the anti-inflammatory activity 
of methanolic and aqueous extracts of root, leaves, and stem of Dipteracanthus patulus 
(Jacq.) Nees  in animal models to support its traditional uses. The anti-inflammatory 
activity using carrageenan was examined. Acute paw edema was induced by injecting 
0.1 mL of 1 % (w/v) carrageenan solution, prepared in normal saline in sub-plantar 
region of the left hind paw of the rat. Measurements were taken at 0, 1, 2, 3 & 4 hours 
after the administration of the carrageenan. The extract which showed best activity were 
further evaluated by egg white, xylene and TPA (12-O-tetradecanoylphorbol-13-acetate) 
induced inflammation in rat models. Methanolic extract (26.4%) and aqueous extract 
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(22.8%) of stem showed the best anti-inflammatory activity in carrageenan induced paw 
edema as well as in the other methods at a dose of 250 mg/kg body weight. The first 
time, confirms the significant anti-inflammatory activity potential of methanolic and 
aqueous extracts of stem of Dipteracanthus patulus on animal models.[12] 
 
A. Manikandan, et al.,2009the antiulcer activity of 50% hydroethanolic leaf 
extract of Ruellia tuberose L. and Dipteracanthus patulus (Jaca) was evaluated in rats 
against pylorus ligated gastric ulcer model. The plant extract were administered orally at 
a dose of 500mg/kg and famotidine at the dose of 20 mg/kg (standard drug). Ulcer 
index was common parameter studied in A the ulcer model, further, the gastric pH, total 
and free acidity, gastric volume and antioxidant leaves such as SOD, CAT, GSH and 
the effect on LPO and protein were analysed. Both the extracts produced significant 
reduction in ulcer index, along with increase in the antioxidant enzyme and protein 
leaves as compared to control group and the lipid peroxidation was reduced in the 
treated and drug administered groups. Thus the plant extracts possess, significant 
antiulcer as well as antioxidant property.[13] 
 
Mamdouh Nabil Samy, et al., 2015 the genus Ruellia L. is sometimes called 
Dipteracanthus; it comprises about 150 species native to tropical and temperate North 
and South America. In this review, the literature data on phytochemical and biological 
investigations of the genus Ruellia are compiled. The well-recognized groups of 
secondary metabolites were flavonoids, lignans, coumarins, alkaloids, triterpenes, 
sterols, phenolic glycosides, phenylethanoids, megastigmane glycosides, 
benzoxazinoid glucosides and others. The extract of this genus as well as pure 
compounds isolated from it have been demonstrated to possess multiple 
pharmacological activities such as wound healing, cardiovascular, anti-hyperglycemic, 
antioxidant, antimicrobial, antibacterial, anticancer, antinociceptive, anti-inflammatory, 
cytotoxic and gastroprotective activities, purgative and angiotensin-converting enzyme 
inhibitory effects, estrogenic and cholinergic properties and antifertility action.[14] 
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 N. Kannikaparameswari, et al., 2013plants have many phytochemicals with 
various bioactivities, including antioxidant, anti-inflammatory and anticancer activities. 
Hence the study focuses on the identification and quantification Lupeol from the 
methanolic leaves extract of Dipteracanthus paulus (Jacq.) Nees. High-Performance 
Liquid Chromatography with Photodiode array detector (HPLC-PDA) was used to 
analyse the compound of interest. The quantity of lupeol was calculated from the 
respective peak areas according to individual standard curves. The content of the 
compound in the extract was 0.04mg/g dry weight (0.004%). The results of showed 
study confirm the presence of good percentage of Lupeol which supports the biological 
potency of the plant.[15] 
 
S. Gopalakrishnan, et al., 2011Dipteracanthus patulus (Jacq.) Nees.(Syn. 
Ruellia patula Jacq).(Acanthaceae) is a medicinal herb traditionally used in the 
treatment of wounds. The methanolic extract of the leaves of Dipteracanthus patulus 
was analyzed by gas chromatography-mass spectrometry (GC-MS). Seventeen 
compounds were identified which included n-Hexadecanoic acid, 9,12,Octadecanoic 
acid (Z, Z) -, Linoleic acid ethyl ester.[16] 
 
N. Murugaiyan, et al., 2015bell weed (Dipteracanthus prostratus) is a medicinal 
herb, traditionally used in the treatment of wounds, anti-cancer, hypoglycemic, anti-
inflammatory, anti-ulcer and anti-oxidant activities. Based on the above information, the 
present study is planned to know the presence of various phytochemicals in the leaves 
of bell weed. Biochemicals like tannin, phenol, terpenoids, flavonoids, amino acid, 
protein, carbohydrate, phylobatannins, volatile oils, hydrolysable tannins, and 
glycosides are present in aqueous and ethanol extracts, whereas steroids are absent in 
both extracts. Gas chromatography-mass spectrometry (GC-MS) analysis showed 36 
compounds viz among those dotriacontane, 2-hexadecen-1-ol,37,11,15-tetramethyl-(R-
(R*, Spinacen, 2,6,10-trimethyl-14-ethylene-14-pentadecane, 2,5,7,8-tetramethyl-2-
(4,8,12-trimethyltridecyl) and stigmasterol were highly present in leaves extract. The 
antimicrobial activity of Dipteracanthus prostratus leaves extract against Escherichia 
coli, Entrobacter aerogenes, Shigella flexneri and Vibrio cholera in ethanol and aqueous 
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extracts. The ethanolic extracts of Dipteracanthus prostrates showed the maximum 
level of zone of inhibition towards the pathogenic bacteria Vibrio cholera and 
Entrobacter aerogenes when compared to aqueous extracts, standard and control and 
the aqueous extract showed the maximum level of zone of inhibition against pathogenic 
bacteria like Entrobacter aerogenes and Shigella flexneri when compared to ethanol 
extract. The results suggest that these phytochemicals and compounds may be used 
against pathogenic bacteria, probably it is used to delivering new drug for cure many 
infectious diseases.[17] 
 
Mudiganti Ram Krishna Rao, et al., 2015Ruellia patula, Luffa aegyptiaca and 
Thunbergia alata are luxuriant and dominant growing herbs on the road sides and on 
waste lands. The present study deals with the comparative phytochemical analysis of 
the ethyl acetate, ethanol and ethanol-water mixture extracts of aerial parts of these 
plants. It was found that some phytochemicals were plant specific whereas some are 
extract specific. The absence of Amino acids, proteins, and flavonoids was detected in 
all extracts of all the three plants. Other phytochemicals like steroids, saponins, 
terpenoids, glycosides etc. were plant specific and extract specific.[18] 
 
N. Saranya, et al., 2014RuelliapatulaJacq (syn: Dipteracanthus patulus) belongs 
to the family Acanthaceae, has numerous medicinal properties but is not exploited much 
in modern medicine. In-vitro antimicrobial activity of the Ruelliapatulajacq leaves 
extracted with Ethanol, Methanol, and Acetone was checked for Bacillus subtilis, 
Escherichia coli, and Aspergillus niger by disc diffusion method. Ethanol was found to 
be the better solvent that its extract showed more activity against Aspergillus niger, 
Escherichia coli and Bacillus subtilis respectively. Preliminary phytochemical screening 
of ethanolic and methanolic extracts showed positive results for alkaloids, steroids, 
phenols, flavonoids, tannins and terpenoids. Genomic DNA was extracted from 
RuelliapatulaJacq leaves using the standard Cetyl Trimethyl Ammonium Bromide 
extraction method. The DNA extracted responded well during PCR amplification and 
RAPD analysis with three gene-specific primers and five random Medicinal aromatic 
plant primers respectively. Chromatographic fingerprinting of the ethanolic extract of the 
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plant leaves was analyzed for compounds present in the sample using analytical type 
HPLC using a C-13 Column and a UV- detector of the RuelliapatulaJacq for the 
detection of the chemical constituents in the plant. Analytical type chromatogram 
revealed the presence of 8 compounds in the extract under scanning at 205 nm. The 
preparative type HPLC chromatogram revealed the presence of 2 major compounds in 
the extract. The collected fractions were subjected to FT-IR spectroscopy and UV-
Visible spectrum analysis. FT-IR Spectrum studies on RuelliapatulaJacq ethanolic 
extract showed the possibility of harbouring secondary metabolites with higher 
pharmaceutical value.[19] 
 
Akhtar, M. Farid, et al., 1992 Cardiovascular profile of Ruellia patula and Ruellia 
Brittoniana was carried on isolated rabbit heart. Crude extract, butanolic and aqueous 
layer of both plants were tested on heart rate, force of contraction and coronary flow. 
Digoxin was used as a controlled drug.All the fraction showed an increase in force of 
contraction expect n-butanolic fraction of R.brittoniana which exhibited depression in all 
parameters. Coronary flow and heart rate displayed nonsignificant decrease. Therefore 
it was concluded that the given Ruellia plant are of cardiotonic nature.[20] 
 
Ahmad, Mansoor et al., 1993 two lignan glycosides identified as 5,5′-
dimethoxylariciresinol-9-O-β-D-glucopyranoside (rupaside) and lyoniresinol-9′-O-β-D-
glucopyranoside along with ethyl-α-D-galactopyranoside, α-and β-D-glucose, and β-D-
fructose have been isolated from Ruellia patula. Their structures were assigned on the 
bases of spectral evidence. Preliminary cardiovascular screening of butanol and 
aqueous fractions suggested possible cardiotonic activity. However, additional studies 
will be required to confirm this type of activity.[21] 
 
Manikandan, A., and D. V. A. Dosset al.,2010the present study was conducted 
to investigate the presence of biochemical contents, trace elements, nutritive value 
evaluation and determination of molecular weight of proteins by SDS-PAGE and 
phytochemicals detection by HPTLC in the leaves and 50% hydroethanolic leaf extracts 
of Ruellia tuberosa L. and Dipteracanthus patulus (Jacq.). The biochemical contents, 
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trace elements, nutritive value were determined by different biochemical methods, trace 
elements presence was detected by using Atomic Absorption Spectroscopy (AAS), 
while the proteins and phytochemicals were detected by using SDS-PAGE and 
HPTLC. Ruellia tuberosa L. and Dipteracanthus patulus (Jacq.) leaves confirmed the 
presence of flavonoids, glycosides, phenols saponins and showed minimum amount of 
trace elements with moderate nutritive value. Vitamins (E, C), total phenolics, 
carotenoid content and nutritive value were found to be greater in the leaves of Ruellia 
tuberosa L. The protein bands obtained in the SDS-PAGE was found to be similar for 
both the plant leaves. Our findings suggest that leaves of Ruellia tuberosa L. 
and Dipteracanthus patulus (Jacq.) is endowed with antioxidant phytochemicals and 
moderate nutritive value could serve as a base for future drugs.[22] 
 
Bumrela, Shrinivas B, et al.,2011the Dipteracanthus patulus (Jacq) nees is 
undershrub belonging to the family acantheaceae. Antimicrobial activity (disc diffusion 
method) and antioxidant activity by different in-vitro methods (DPPH, hydrogen 
peroxide, nitric oxide radical scavenging and reducing power) of methanolic extract of 
Dipteracanthus patulus (MEDP) was evaluated. The qualitative and quantitative 
estimation of β-carotene and β- sitosterol in MEDP was carried out by high performance 
thin layer chromatography (HPTLC). The total phenolic content of was determined by 
Folin-Ciocalteu method. Experimental findings indicate promising antimicrobial activity 
(antibacterial and antifungal) and potent antioxidant activity of MEDP. In addition, 
phytochemical analysis and spectral studies of MEDP were also performed. It is 
presumed that antimicrobial and antioxidant activity observed with MEDP may largely 
be attributed to the presence of major phytoconstituents (β-carotene, β-sitosterol and 
iridoid glycosides) and other minor components may participate as promoters.[23] 
 
P. Senthilkumar, et al., 2013the methanol leaf extracts of Ruellia tuberosa 
showed significant antibacterial activity against Escherichia coli, 
Pseudomonasaeruginosa, Klebsiella pneumonia, Bacillus subtilis, Proteus mirablis and 
antifungal activity against Aspergillussp, Mucorsp, Penicilliumsp and Fusarium sp. The 
antibacterial potential of Ruellia tuberose methanol extract was tested by using Agar 
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welldiffusion method. The (100mg/ml) leaf extract showed maximum inhibition against 
Proteus mirablis (7mm). Further the extract showed maximum zone of inhibition against 
the fungus of Aspergillus sp (8mm). Phytochemical tests were performed and showed 
that the antibacterial activity of plant Ruellia tuberosa leaves was due to the presence of 
phytochemical compounds like alkaloids, tripenoid, tannins, glycosides, saponins.             
GC-MS analysis revealed the presence of 27 compounds.[24] 
 
V. Nagarjuna Reddy, et al., 2013 antitumor activity of methanolic extracts of 
250, 500 mg/kg of Ruellia tuberosa leaves was evaluated against Ehrlich ascites 
carcinoma (EAC) tumor in mice. Acute and short-term toxicity studies were performed 
initially in order to ascertain the safety of methanolic extracts of Ruellia tuberosa. 
Tumour cells (1×106cells/mice) were injected into the right hind limb (thigh) of solid 
tumour group animals subcutaneously and the tumour is allowed to develop for 11 days 
and the treatment is started from 12th day for a period of 20 days. The effect of 
methanolic extracts of Ruellia tuberosa on the growth of tumor, life span of EAC bearing 
hosts and simultaneous alterations in the haematological profile and histopathological 
profile were estimated. The methanolic extracts of Ruellia tuberosa showed decrease in 
tumor size, average body weight, mean survival time thereby increasing life span of 
EAC tumor bearing mice. Haematological profile reverted to more or less normal levels 
in extracts treated mice. Histopathology has minimal effects when compared but a 
significant variation is seen.[25] 
 
S. Ramadevi, et al., 2013 estimate the phytochemical profile and antimicrobial 
activity of medicinal plant Ruellia patula (L.) against human pathogenic bacteria. 
Medicinal plants are the effective source for the development of drug against several 
diseases. Nowadays, medicinal plants were used to treat most diseases among 
humans because of its medicinal value. In Ayurveda and Siddha, many medicinal plants 
have been recommended for the management of common diseases. The extraction was 
done by using different solvent such as ethanol, methanol and acetone by using 
standard procedures. The antibacterial assay was carried by using agar well method 
with different organisms and also antifungal activity against Aspergillus nigerusing disc 
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diffusion method. The ethanolic extract of R. patula L. (0.4 mg/mL) showed higher 
antibacterial activity against Gram positive bacteria and Gram negative bacteria. In the 
antifungal activity also ethanolic extract shows highest activity compare to other extract. 
From the present work, we conclude that the ethanolic extract of plant R. patula L. have 
potential of antibacterial activity and antifungal activity because of its secondary 
metabolites in the plant which responsible for biological activities. Due to the presence 
of phyto‐constituent in the plant extract may control the bacterial growth either in high 
concentration/long durations and it may have the ability to control the human pathogenic 
organisms.[26] 
 
khurram afzal, et al., 2015 Ruellia is a genus of flowering plants commonly 
known as Ruellias or Wild Petunias which belongs to the family Acanthaceae. It 
contains about 250 genera and 2500 species. Most of these are shrubs, or twining 
vines; some are epiphytes. Only a few species are distributed in temperate regions. 
They are distributed in Indonesia and Malaysia, Africa, Brazil, Central America and 
Pakistan. Some of these are used as medicinal plants. Many species of the genus has 
antinociceptive, antioxidant, analgesic, antispasmolytic, antiulcer, antidiabetic and anti-
inflammatory properties. The phytochemicals constituents: glycosides, alkaloids, 
flavonoids and triterpenoids are present. The genus has been traditionally claimed to be 
used for the treatment of flu, asthma, fever, bronchitis, high blood pressure, eczema, 
and diabetes. The objective of this review article is to summarize all the 
pharmacological and phytochemical evaluations or investigations to find area of gap 
and endorse this genus a step towards commercial drug. Hence, further work required 
is to isolate and characterize the active compounds responsible for these activities in 
this plant and bring this genus plants to commercial health market to serve community 
with their potential benefits.[27] 
 
Bo Eng Cheong, et al., 2013 antioxidant and anti-proliferative activities of Sabah 
Ruellia tuberosa. The total phenolic and flavonoid contents of the plant extracts were 
determined by using Folin-Ciocalteau and aluminium chloride colorimetric assays, 
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respectively. The antioxidant activity of the plant extracts was evaluated using DPPH 
free radical scavenging assay while the anti-proliferative activity was evaluated using 
MTT assay against the human breast cancer (MCF-7) and cervical cancer (HeLa) cell 
lines. The methanol leaf extract was found to possess the highest total phenolic content 
(82.67 ± 2.09 mg GAE/g) while the ethyl acetate leaf extract was found to possess the 
highest total flavonoid content (152.77 ± 4.68 mg Cat/g). The ethyl acetate leaf 
possessed the highest radical scavenging activity, with IC50 of  720 μg/ml. Meanwhile, 
the methanol stem extract showed the highest anti-proliferative activity against MCF-7 
cancer cells, with IC50 of 22 μg/ml but none of the extracts exhibited strong anti-
proliferative activity against the HeLa cancer cell lines. Significant correlation was found 
between the total phenolic/flavonoid contents with the total antioxidant activity while 
weak correlation was found between the total phenolic/flavonoid contents with the 
inhibition of MCF-7 cell proliferation. Our findings indicate that Sabah Ruellia tuberosa 
could be a potential source for natural antioxidant as well as chemo-preventive agent 
against breast cancer in future. Thus, further isolation and characterization of the 
respective bioactive compounds from the plants are necessary.[28] 
 
M. Rajan, et al., 2012 Ruellia tuberosa Linn belongs to family acanthaceae is a 
large sized plant distributed throughout India, Srilanka and Nepal. methanolic extract of 
Ruellia tuberosa linn leaves in normal and alloxan induced diabetic rats. The 
Preliminary phytochemical screening shows the presence of carbohydrates, glycosides, 
phytosteroids, flavonoids, tannins, fixed oils & fats. Diabetes was induced in Albino rats 
by administration of alloxan monohydrate (150mg/kg, i.p).The methanol extract of 
Ruellia tuberosa linn leaves at a dose of 100 and 200mg/kg of body weight was 
administered at single dose per day to diabetes induced rats for a period of 14 days. 
The effect of methanol extract of Ruellia tuberosa linn leaves on blood glucose, serum 
lipid profile [total cholesterol (TC), triglycerides (TG), high density lipoprotein – 
cholesterol (HDL-C), low density lipoprotein – cholesterol (LDL-C), very low density 
lipoprotein – cholesterol (VLDL-C) and serum protein, albumin, globulin, serum 
enzymes [serum glutamate pyruvate transaminases (SGPT), serum glutamate 
oxaloacetate transaminases (SGOT), alkaline phosphatase (ALP)], were measured in 
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the diabetic rats. The methanol extract of Ruellia tuberosa linn leaves elicited significant 
reductions of blood glucose (P<0.05), lipid parameters except HDL-C, serum enzymes 
and significantly increased HDL-C at the dose of 200mg/kg was compared with the 
standard drug Glibenclamide (5gm/kg). From the above results, it is concluded that 
methanol extract of Ruellia tuberosa linn leaves possesses significant antidiabetic, 
antihyperlipidaemic and hepatoprotective effects in alloxan induced diabetic rats.[29] 
 
M. Ashraful Alam, et al., 2009  the ethanol extract of Ruellia tuberosa L. 
(Acanthaceae) was evaluated for its antinociceptive and anti-inflammatory properties in 
experimental mice and/or rat models. In the hot-plate test, the group that received a 
dose of 300 mg/kg showed maximum time needed for the response against thermal 
stimuli (5.11 ± 0.12), which was similar to that of diclofenac sodium (5.96 ± 0.18), a well-
known painkiller. The maximum possible analgesia (MPH) was 1.93 for the extract dose 
300 mg/kg, while that for diclofenac was 2.29 after 60 min of administration in the hot 
tail-flick method. The extract at 500 and 250 mg/kg doses showed significant reduction 
in acetic acid-induced writhing in mice with a maximum effect of 63.21% reduction at 
500 mg/kg dose, which was similar to positive control diclofenac sodium (66.98%). The 
extract also demonstrated significant inhibition in serotonin and egg albumin-induced 
hind paw edema in rats at the doses 100, 200 and 300 mg/kg (serotonin-induced 
edema 35.85, 46.78 and 55.18%; egg albumin-induced edema 42.96, 48.30, and 
55.61% inhibition after 1-4 h). The anti-inflammatory properties exhibited by the extract 
were comparable to that of indomethacin at a dose of 5 mg/kg (serotonin-induced 
edema 53.22; egg albumin- induced edema 57.01% inhibition after 4 h).[30] 
 
Christine O. Wangia, et al., 2016 medicinal plants play a significant role in 
treatment and prevention of many diseases in humans worldwide. Ruellia species 
belong to the family Acanthaceae and have been used widely for medicinal purposes. 
The objective of this study was to evaluate the comparative In vitro antioxidant activity 
of two Kenyan Ruellia species viz. Ruellia lineari-bracteolata (RLB) and 
Ruelliabignoniiflora (RBK). The plant materials were extracted with aqueous, ethyl 
acetate and methanol. The extracts were subjected to phytochemical screening 
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according to standard procedures and anti-oxidant activity determined using 2, 2-
Diphenyl-1-picrylhydrazyl (DPPH) assay. Comparative anti-oxidant activity for 
methanolic, ethyl acetate and aqueous extracts of RLB and RBK exhibited IC50 values 
of (2.7, 29.3, 7.2 and 24.4, 237.2, 66.4 μg/ml) respectively. Among the three extracts, 
methanolic extract showed better activity ( 2.7 μg/ml) comparable to ascorbic standard 
(2.1 μg/ml). Between the two Ruellia species, RLB showed a significant difference 
(p<0.05) in anti-oxidant activity as compared to RBK extracts. Phytochemical screening 
showed the presence of terpenoids, saponins, flavonoids, tannins and glycosides. 
Flavonoids and tannins are the main phytoconstituents responsible for anti-oxidant 
activity. In conclusion, the potent anti-oxidant activity of these plants makes them useful 
in development of medicinal drugs for treatment and prevention of degenerative 
diseases.[31] 
 
Al-Said, Mansoor S, et al., 1986 the effect of mastic, a concrete resinous 
exudate obtained from the stem of the tree Pistacia lentiscus, has been studied on 
experimentallyinduced gastric and duodenal ulcers in rats. Mastic at an oral dose of 500 
mg/kg produced a significant reduction in the intensity of gastric mucosal damage 
induced by pyloric ligation, aspirin, phenylbutazone, reserpine and restraint + cold 
stress. It produced a significant decrease of free acidity in 6-h pylorus-ligated rats and a 
marked cytoprotective effect against 50% ethanol in rats which could be reversed by 
prior treatment with indomethacin. The protective effect was not seen when it was given 
intraperitoneally in phenylbutazone and restraint + cold stress models. The reduction in 
the intensity of ulceration in cysteamine-induced duodenal ulcers was not found to be 
statistically significant in mastic-pretreated rats. The results suggest that mild 
antisecretory and a localized adaptive cytoprotectant action may be responsible for its 
anti-ulcer activity. These observations support the results of an earlier study on the 
clinical effectiveness of mastic in the therapy of duodenal ulcer.[32] 
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Abdulla, M. A, et al.,   2010 the anti-ulcerogenic activity of ethanol extract 
of Centella asiatica against ethanol-induced gastric mucosal injury in rats.  Five groups 
of adult Sprague Dawley rats were orally pre-treated respectively with carboxymethyl 
cellulose (CMC) solution (ulcer control group), Omeprazole 20 mg/kg (reference group), 
and 100, 200 and 400 mg/kg C. asiatica leaf extract in CMC solution (experimental 
groups), one hour before oral administration of absolute ethanol to generate gastric 
mucosal injury.  Rats were sacrificed and the ulcer areas of the gastric walls were 
determined. Grossly, the ulcer control group exhibited severe mucosal injury, whereas 
pre-treatment with C. asiatica leaf extract exhibited significant protection of gastric 
mucosal injury. Histological studies revealed that ulcer control group exhibited severe 
damage of gastric mucosa, along with edema and leucocytes infiltration of submucosal 
layer compared to rats pre-treated with C. asiatica leaf extract which showed gastric 
mucosal protection, reduction or absence of edema and leucocytes infiltration of 
submucosal layer. Acute toxicity study did not manifest any toxicological signs in rats. 
The finding suggests that C. asiatica leaf extract promotes ulcer protection as 
ascertained grossly and histologically compared to the ulcer control group.[33] 
 
Shukla, A, et al., 1999 the healing of an open wound depends on two major 
phenomena: (1) epithelialization, ie replication and movement of epithelial cells; and (2) 
formation and contraction of granulation tissue. This second phenomenon is essential in 
order to maintain tissue continuity, to reduce the size of the wound and to produce a 
permanent scar. Pathological phenomena resulting in fibrosis (eg pulmonary fibrosis, 
kidney fibrosis, liver cirrhosis and stroma reaction to epithelial tumours) are 
characterized by a more permanent presence of a connective tissue bearing features of 
granulation tissue that results in excessive extracellular matrix deposition and in 
production of soft tissue deformation. In most cases, wound healing ends by scar 
formation, ie permanent deposition of connective tissue characterized by the presence 
of fibroblasts, extracellular matrix components, among which collagen is the most 
important, and small vessels. In chronic pathological changes, such as hypertrophic 
scars and fibrotic lesions, an excess of extracellular matrix deposition may continue for 
several years.[34] 
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Gabbiani. G, et al., 2003 the preliminary wound healing activity of Portulaca 
oleracea was studied using Mus musculus JVI-1. For this purpose fresh homogenized 
crude aerial parts of Portulaca oleracea were applied topically on the excision wound 
surface as single and two doses in different amounts. Wound contraction and tensile 
strength measurements were used to evaluate the effect of Portulaca oleracea on 
wound healing. The results obtained indicated that Portulaca oleracea accelerates the 
wound healing process by decreasing the surface area of the wound and increasing the 
tensile strength. The greatest contraction was obtained at a single dose of 50 mg and 
the second greatest by two doses of 25 mg. Measurements of tensile strength and 
healed area were in agreement.[35] 
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Chapter 3 
                                       AIM AND OBJECTIVES 
 
Peptic ulcer disease (PUD) is one of the most common gastrointestinal disorders, 
which causes a high rate of morbidity particularly in the population of non-industrialized 
countries. Peptic ulcer occurs due to an imbalance between the aggressive and the 
defensive factors.  
The modern approach to control gastric ulceration is to inhibit gastric acid 
secretion, to promote gastro protection, block apoptosis and stimulate epithelial cell 
proliferation for effective healing. Anti-secretory drugs such as proton pump inhibitors 
(omeprazole, lansoprazole, etc.) and histamine H2-receptor blocker (ranitidine, 
famotidine, etc.) are extensively used to control increased acid secretion. These 
medicines are considered safer because of the natural ingredients with no side effects.  
Wound healing is the process of repair that follows injury to the skin and other 
soft tissues. Following injury, an inflammatory response occurs and the cells below the 
dermis begin to increase collagen production. Later, the epithelial tissue is regenerated 
A wound is a disruption in the continuity of cell. It is an intricate process in which 
the skin repairs . 
The need of present study reveals about the anti-ulcer and wound healing 
activities on animal models. 
The objectives of the present study are: 
1. Collection and authentication of plant and the plant parts. 
2. Extraction of plant materials with ethanol and chloroform. 
3. Carrying out preliminary phytochemical screening. 
4. Carrying out TLC analysis for both plant extracts. 
5. To evaluate the drug and excipient interactions by FT-IR spectral studies. 
6. To evaluate the following Pharmacological activities of leaf extracts of the 
selected    plant using the various standard experimental models. 
i. Anti-Ulcer studies. 
ii. Wound healing activity. 
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Chapter 4 
MATERIALS AND METHODS 
4.1Collection and authentication of plant and the plant parts 
The plant materials used in this study were leaves of Dipteracanthus patulus 
(Jacq). (Family - Acanthaceae) is collected from the sengundrapuram, (Virudhunagar 
Dist, Tamil Nadu, India.). The plant was authenticated by Dr.Stephen, Department of 
Botany, American College, Madurai, India. 
 
4.2 Animals used 
          Adult male albino rats (150 - 200g) were used in this study. They were maintained 
in clean, sterile, polypropylene cages and fed with commercial pellet rat chow (M/S 
Hindustan lever limited, Bangalore, India) and water ad libitum. The study was approved 
by the Institutional Ethical Committee, which follows the guidelines of Committee for the 
Purpose of Control and Supervision of Experimental Animals (CPSCEA). 
 
4.3 Preparation of   Ethanol and Chloroform extracts of D.patulus (Jacq) Leaf. 
D.patulus Leaf collected was dried at room temperature under shade 15 days 
and coarsely powdered. The powdered materials were extracted with ethanol and 
chloroform. The last traces of the solvent were removed and concentrated to dryness 
under vacuum using a rotary evaporator. The dried extract was weighed and then kept 
at -4ºC until ready for use. The yield of the extract was 66.42 % (w/w) and 33.68 % 
(w/w). In each experiment, the extract was diluted with water to desired concentration. 
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4.4 Materials used for the studies: 
4.4.1 Drugs used 
Ranitidine    - Aciloc injection (Cadila) 
Neomycin          - Neos (Universal) 
Diclofenac sodium  - Cofenac (Cipla)  
Saline    - DNS (Baxter) 
4.4.2 Chemicals used 
Ethanol   -  CDH (central drug house, New Delhi) 
Chloroform   -  CDH (central drug house, New Delhi) 
Silica gel (TLC grade) -  CDH (central drug house, New Delhi) 
4.5 Methodology [36-37]  
4.5.1 Preliminary Phytochemical Screening for D.patulus (Jacq). 
4.5.1.1 Test for Carbohydrate 
4ml of the extract was dissolved separately in 4 ml of d .H2O and filtered. The 
filtrate was subjected to the following tests to detect the presence of carbohydrate. 
i) Molisch’s test 
The filtrate was treated with 2-3 drops of 1% alcoholic α-napthol solution and 2 
ml of concentrated H 2S0 4 was added along the sides of the test tubes. Appearance of 
brown ring at the junction of two liquids shows the presence of carbohydrate. 
ii) Fehling’s test 
The filtrate was treated with 1 ml of Fehling, s solution A and B and heated on 
the water bath. A reddish precipitate was obtained show the presence of carbohydrate. 
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4.5.1.2 Test for proteins and free amino acid 
3ml of extract was dissolved in few ml of distilled water and treated with following 
reagents 
i) Million’s Reagent: - Appearance of red color shows the presence of proteins and 
free amino acids. 
ii) Ninhydrin Reagent: - Appearance of purple color shows the presence of proteins 
and free amino acids. 
iii) Biuret test: - Equal volume of 5% sodium hydroxide solution and 1% copper 
sulphate solution were added, appearance of pink or purple color shows the presence 
of proteins and free amino acids. 
4.5.1.3 Test for phenolic compounds 
3ml of extract was taken in distilled water and test for the presence of phenolic 
compounds was carried out with dilute ferric chloride solution (5%w/v) - Appearance of 
violet color indicates the presence of phenolic compounds. 
4.5.1.4 Test for flavonoids 
i) Aqueous NaOH solution 
3ml of extract, dissolved in aqueous sodium hydroxide. Appearance of yellow 
color indicates the presence of flavonoids. 
ii) Conc. Sulphuric acid 
2ml of extract concentrated sulphuric acid was added. Appearance of Yellow 
orange color indicates the presence of flavonoids. 
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4.5.1.5 Test for Alkaloids 
Wagner test: 
Added 2ml filtrate of extract with 1% HCl and applied steam. 1ml of the solution 
added with 6 drops of Wagner‟s reagent. Appearance Brownish-red precipitate indicates 
the presence of alkaloids. 
4.5.1.6 Test for Tannin. 
Braemer’s test  
10% alcoholic ferric chloride is added to 2 ml of  extract. An appearance of Dark 
blue coloration of the solution indicates the presence of tannin. 
4.5.1.7 Test for reducing sugar. 
Fehling test 
Added 25ml of diluted sulphuric acid (H2 SO4) to 5ml of extract in a test tube and 
boil for 15mins. Then cool it and neutralize with 10% sodium hydroxide to pH 7 and 5ml 
of Fehling solution.  An appearance of Brick red precipitate indicates the presence of 
reducing sugar. 
4.5.1.8 Test for Glycosides  
(a) Legal test: Dissolved the extract in pyridine and added sodium nitroprusside 
solution to make it alkaline. The formation of pink red to red color shows the presence of 
glycosides.  
 (b) Baljet test: To 1 ml of the test 50% methanolic extract added 1 ml sodium 
picrate solution and the change yellow to orange color reveals the presence of 
glycosides.  
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4.6 THIN LAYER CHROMATOGRAPHY 
 Thin layer chromatography is so widely used that is has become an essential technique 
for analyst and research workers. TLC is the almost universal analytical technique in chemical 
analysis for organic and inorganic matter. 
 TLC is a simple rapid method carried out using thin layer of adsorbents on plates. TLC 
not only combines the advantage of paper and column chromatography but in certain aspects it 
is found to be superior to either method.  
 TLC is an important tool in the separation, identification and estimation of different 
classes of natural products. When a mixture containing different components is made to ascend 
in a TLC plate with the help of a solvent which act as a mobile phase, there will be a preferential 
adsorption of different components at different places on the plate. The result is the separation 
of components. 
4.6.1Preparation of TLC Plate: 
 80 gm of silica gel G was weighed and shaken to a homogenous suspension with 85 ml 
of distilled water for 90 sec. This suspension was poured in TLC applicator which was adjusted 
to 0.25 mm thickness 20 carriers‟ transparence of layer disappeared. The plates were dried in 
hot air oven at 110 c for 30 minutes (activation). The plates were then stored in a dry 
atmosphere and used whenever required. 
 
 
 
 
 
 
 
 
    
                                                                                                             Arulmigu Kalasalingam College of Pharmacy 
 
D e p a r t m e n t  o f  P h a r m a c o l o g y                                            30 
  
4.6.2 Application of extracts for separation: 
 The various diluted extracts spotted on a TLC plate 2 cm above its bottom using 
capillary tube. Most solution for application was between 0.1-1 % strength. The starting 
point was equally sized as far possible and spots had diameter ranging from 2-5 mm. 
Mobile phase : 
 Chloroform: Ethanol 9 : 1 
 Detecting agent:   Iodine 
  Rf value =    Distance travelled by the solute   
                                            Distance travelled by the solvent 
 
 
4.7 Characterization of Phytoconstituents using spectroscopy techniques: 
FT-IR stands for Fourier Transform Infra Red, the preferred method of infrared 
spectroscopy. In infrared spectroscopy, IR radiation is passed through a sample. Some 
of the infrared radiation is absorbed by the sample and some of it is passed through 
(transmitted). The resulting spectrum represents the molecular absorption and 
transmission, creating a molecular fingerprint of the sample. 
All the separated compounds from ethanol and chloroform extract of D.patulus 
leaf extract was characterized by FTIR spectroscopy technique. 
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4.8 ANTI-ULCER ACTIVITY [38] 
4.8.1 ASPIRIN INDUCED ULCER MODEL  
 Animals were divided into four groups of four animals each. The dosage of drugs 
was administered by following 
  
           GROUP I  : Control (Tween 80, 5mg/kg) orally 
 GROUP II  : Standard Ranitidine (30 mg/kg) orally   
 GROUP III  : Ethanolic extract of D.patulus (100 mg/kg) orally. 
 GROUP IV  : Chloroform extract of D.patulus (100 mg/kg) orally. 
 
 The gastric ulcer was induced in each rat by administrating aspirin 500 mg/kg 
orally. After 45 min ethanolic and chloroform extract of D.patulus and other drugs were 
administered for seven days. The animals were sacrificed and stomach was excised 
and cut along the greater curvature, rinsed gently with saline to remove the gastric 
content and blood clots and the ulcer index was calculated. 
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4.8.2 ETHANOL-INDUCED ULCER MODEL  
The animals were divided into four groups. The gastric ulcers were induced in 
rats by administrating absolute ethanol (99%) (1 ml/200 gm) orally after 45 min 
ethanolic and chloroform extract of D.patulus and other drugs were administered for 
seven days. The animals were sacrificed under anaesthetized conditions, and the 
stomach was dissected out and ulcer index was calculated. 
 
           GROUP I  : Control (Tween 80, 5mg/kg) orally. 
 GROUP II  : Standard Ranitidine (30 mg/kg) orally. 
 GROUP III  : Ethanolic extract of D.patulus (100 mg/kg) orally. 
 GROUP IV  : Chloroform extract of D.patulus (100 mg/kg) orally. 
  
                  Ulcer index (UI) was calculated by the following formula 
    Ulcer index = 10/x 
   X= Total mucosal area / total ulcerated area 
The percentage inhibition was calculated by the following formula 
  % inhibition = UI control – UI treated   X 100 
                 UI control 
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4.9 WOUND HEALING ACTIVITY [39] 
4.9.1 IN VIVO EXCISION WOUND MODEL: 
The animals were numbered, weighed and then divided into four groups with five 
animals in each as follows: 
           GROUP I  :         control, simple ointment. 
 GROUP II  : 2%, w/w, Neomycin ointment. 
 GROUP III  : 20%, w/w, Ethanolic extract of D.patulus. 
 GROUP IV  : 20%, w/w, Chloroform extract of D.patulus. 
 
Hairs were removed from the dorsal thoracic central region of anaesthetised 
mice. The mice were depilated on the back. One excision wound was inflicted by cutting 
away a 300 mm2 full thickness of skin from a predetermined area; the wound was left 
undressed to the open environment. 
Percentage of wound contraction, 
 
Initial wound size – Specific day wound size x 100 
                                                 Initial wound size 
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4.9.2 IN VITRO CHORIOALLANTOIC MEMBRANE MODEL [40-41] 
 Embryonated chicken eggs (9 days old) were selected then divided into four 
groups and a small window, (1cm2) was made in the shell follows 
 
 GROUP I  : Negative Control saline. 
GROUP II  : Positive Control Diclofenac sodium (50 μg/ml) 
GROUP III  : Ethanolic extract of D.patulus. (500 μg/ml) 
GROUP IV  : Chloroform extract of D.patulus. (500 μg/ml) 
 
Whatman No. 1 filter paper was Small disks were generated using a standard 5 
mm hole puncher, sterilized by autoclaving and stored for further use. The pre-sterilized 
filter disks were saturated with different concentrations of the crude extract, from 500 
μg/ml, and the control solutions. Diclofenac sodium 50 μg/ml and sterile saline were 
used as positive and negative controls respectively. Eggshell window was closed and 
incubated at 370 C for 72 hrs. The window was then opened and the growth of new 
capillary blood vessels were observed and finally compared with the positive and 
negative control.  
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Chapter 5 
EXPERIMENTAL RESULTS 
5.1 Preliminary phytochemical screening 
 
The phytoconstituents were identified by chemical tests, which showed the 
presence of various phytoconstituents in ethanolic and chloroform extract of 
D.patulus(Jacq) Presented in Table no.1. 
Table no: 1 
Preliminary phytochemical screening of the ethanolic and chloroform extract of 
D.patulus (Jacq). 
 
S. No. Constituents Ethanol extract of 
D.patulus 
chloroform extract 
of D.patulus 
1. Carbohydrate - - 
 
2. Proteins & amino acids - - 
3. Flavonoids + + 
 
4. Alkaloids + + 
 
5. Tannin + + 
 
6. Glycosides + - 
 
7. Anthroquinone + + 
 
8. Tri-terpenoids + + 
 
9. Saponins + - 
 
10. Phenol - + 
 
11. Steroids + + 
 
 
  Where, + = Presence, − = Absence 
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5.2   Rf values of Ethanolic and Chloroform extracts of   D.patulus(Jacq). 
 
Table 2: Rf values 
 
 
S.no 
 
Extracts 
 
 
Rf value 
 
1. 
 
Ethanol extract of D.patulus 
 
 
0.96 
 
2. 
 
Chloroform extract of D.patulus 
 
 
0.92 
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Fig no 1: Ethanolic extract of D.patulus (Jacq) in TLC plate. 
 
Rf value =           4.8              = 0.96 
                  5 
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Fig no 2: Chloroform extract of D.patulus (Jacq) in TLC plate. 
 
 
Rf value =          4.6       = 0.92 
                            5 
 
 
 
 
    
                                                                                                             Arulmigu Kalasalingam College of Pharmacy 
 
D e p a r t m e n t  o f  P h a r m a c o l o g y                                            39 
  
5.3 FT-IR studies of separated compound 
The IR spectrum showed an absorption of Ethanolic extract at 3020, 2927, 2148, 
2364 cm-1 indicating the presence of C-H stretching of CH3, C-H stretching of CH2, 
C=C stretching, and chloroform extract at 1045,1087,1381,1649 cm-1  indicating the 
presence of  C-H stretching, C-O bending, C=C stretching,  The reports are showed in 
Fig no- 24 & 25 
 
5.4 ANTI-ULCER ACTIVITY 
5.4.1 Effect of Aspirin-Induced Ulcer 
The results obtained in the experimental model of aspirin-induced gastric 
ulceration in rats are presented in Table 3. The ethanolic and chloroform extract was 
found to possess remarkable ulcer-protective properties at100 mg/kg. The effect of 
ulcer protection of ethanol extract of D.patulus(Jacq)  (45.24%) was observed at 100 
mg/kg and chloroform extract of  D.patulus(Jacq) (38.24%) was observed at 100mg/kg, 
whereas the standard drug ranitidine gave (69.65%) of ulcer protection. 
 
5.4.2 Effect of Ethanol-Induced Ulcer 
The results obtained in the experimental model of ethanol -induced gastric 
ulceration in rats is summarized in Table 4. The ethanolic and chloroform extract was 
found to possess remarkable ulcer-protective properties at 100 mg/kg. The effect of 
ulcer protection of ethanol extract of D.patulus(Jacq)  (52.69%) was observed at 100 
mg/kg and chloroform extract of  D.patulus(Jacq) (48.34%) was observed at 100mg/kg, 
whereas the standard drug ranitidine gave (73.21%) of ulcer protection. 
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5.5 WOUND HEALING ACTIVITY 
IN VIVO MODEL 
5.5.1 Excision wound model  
The results of excision wound model are shown in table 5. The ethanolic and 
chloroform extract showed significant wound healing activity as compared to control and 
standard in excision wound model. It is observed that the wound contracting ability of 
the 20% (w/w) extract ointment treated groups showed significant wound healing from 
the fourth day onwards. The wound closure time was lesser, as well as the percentage 
of wound contraction was more with the 20% (w/w) extract ointment treated group. 
Significant increase in the rate of wound contraction has been observed on day 14 (99. 
01 %) on the 20 % (w/w) of chloroform extract treated animal. The post wounding was 
observed in 20 % (w/w) extract ointment treated animals and Neomycin ointment 
treated animals 100 % wound closure was observed on 16th day. 
 
IN VITRO MODEL 
5.5.2 Chorioallantoic membrane model (CAM) 
 The result was tabulated by counting the number of blood vessels in various 
treatments. Ethanolic and chloroform extract, positive control promoted an increase in 
number of blood vessels compared to negative control saline. 
 Treated 500 μg/ml Ethanolic and chloroform extract group and 50 μg/ml 
Diclofenac sodium positive control treated group was observed formation of new blood 
vessels. (Fig no 20, 21, & 22) 
The negative control does not show the formation of blood vessels. (Fig no 23) 
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ANTI-ULCER ACTIVITY 
Aspirin-Induced Ulcer model 
 
Fig-3 control- Aspirin induced ulcer model. 
 
 
Fig-4 STD Ranitidine-  treated Aspirin induced ulcer model. 
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Fig- 5 Ethanolic extract of D.patulus(Jacq) 100mg/kg treated- Aspirin induced ulcer 
model. 
 
 
  
 
 
 
 
 
 
 
  Fig- 6 Chloroform extract of D.patulus(Jacq) 100mg/kg treated- Aspirin induced ulcer 
model. 
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Ethanol Induced Ulcer model 
 
 
 
 
 
 
 
 
 
 
Fig-7 control-Ethanol induced ulcer model. 
 
 
Fig-8 STD Ranitidine  treated- Ethanol induced ulcer model. 
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Fig- 9 Ethanolic extract of D.patulus (Jacq) 100mg/kg treated- Ethanol induced ulcer    
model. 
 
 
 
Fig- 10 Chloroform extract of D.patulus(Jacq) 100mg/kg treated- ethanol induced ulcer 
model. 
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WOUND HEALING ACTIVITY 
Excision wound model 
 
FIG NO 11: Excision wound model on initial day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 12: Excision wound model on 2nd day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
 
 
. 
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FIG NO 13: Excision wound model on 4th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 14: Excision wound model on  6th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 15: Excision wound model on 8th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 16: Excision wound model on 10th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 17: Excision wound model on 12th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 18: Excision wound model on 14th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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FIG NO 19: Excision wound model on 16th day after wound creation. 
a) Control,  
b) 2 % w/w of standard drug treated animal, 
c) 20 % w/w of Ethanolic extract of D.patulus treated animal, 
d) 20 % w/w of Chloroform extract of D.patulus treated animal. 
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Chorioallantoic membrane model (CAM) 
 
  Fig no 20: Treated 500 μg/ml of Ethanolic extract of D.patulus. 
 
 
Fig no 21: Treated 500 μg/ml of Chloroform extract of D.patulus.  
    
                                                                                                             Arulmigu Kalasalingam College of Pharmacy 
 
D e p a r t m e n t  o f  P h a r m a c o l o g y                                            55 
  
 
            Fig no 22: Positive Control Diclofenac sodium-50 μg/ml. 
 
 
Fig no 23: Negative Control saline. 
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                       Fig no 24: FT-IR Studies on D.patulus (Jacq) Ethanolic extract. 
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Fig no 25: FT-IR Studies on D.patulus (Jacq) Chloroform extract. 
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Table 3: Effect of Dipteracanthus patulus leaf extracts on Aspirin induced ulcer 
model. 
 
S.No Treatment Dose (mg / kg) 
 
Ulcer index 
 
Protection % 
 
1 
 
Control tween 80 
 
5mg / kg 
 
5.57 ± 0.23 
 
--- 
 
2. 
 
Ranitidine 
 
30 mg / kg 
 
1.69 ± 0.10** 
 
69. 65 % 
 
3. 
 
Ethanolic extract 
 
100 mg / kg 
 
3.05 ± 0.12** 
 
45.24% 
 
4. 
 
Chloroform extract 
 
100 mg / kg 
 
3.44 ± 0.20 
 
38.24 % 
 
Results are expressed as mean  SEM from four observations as compared to standard 
group the one way ANOVA is Graph Pad‟s software method, (**P< 0.0001) by 
conventional criteria; this difference is considered to be extremely statistically 
significant. 
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Table 4: Effect of Dipteracanthus patulus leaf extracts on Ethanol induced ulcer 
model. 
S.No Treatment Dose (mg / kg) 
 
Ulcer index 
 
Protection % 
1 
 
Control tween 80 
 
5 mg / kg 
 
5.75 ± 0.08 
 
--- 
2. 
 
Ranitidine 
 
30 mg / kg 
 
1.54 ± 0.13** 
 
73.21% 
3. 
 
Ethanolic extract 
 
100 mg / kg 
 
2.72 ± 0.09** 
 
52.69% 
4. 
 
Chloroform extract 
 
100 mg / kg 
 
2.97 ± 0.20 
 
48.34% 
 
 
Results are expressed as mean  SEM from four observations as compared to standard 
group the one way ANOVA is Graph Pad‟s software method, (**P< 0.0001) by 
conventional criteria; this difference is considered to be extremely statistically 
significant. 
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Table 5: Effect of Dipteracanthus patulus leaf extracts on Excision wound model. 
 
 
Post wounding 
days 
 
Wound area (mm2) (mean ± SEM) and percentage of wound 
contraction 
 
CONTROL 
 
STANDARD 
DRUG 
2%, w/w 
 
ETHANOLIC 
EXTRACT 
20%, w/w 
 
CHLOROFORM 
EXTRACT 20%, 
w/w 
 
0 
 
 
505.33± 11.87 
 
519.90 ± 6.69 
 
505.16 ± 5.02 
 
509.67 ± 5.65 
 
2 
 
476.33 ± 2.08 
(5.7%) 
 
452.68 ± 6.09 
(12.92%) 
 
451.56 ±15.33 
(10.61%) 
 
453.77 ± 7.17 
(10.96%) 
 
4 
 
448.54 ± 9.90 
(11.23%) 
 
350.64 ±2.81* 
(32.55%) 
 
348.76 ± 2.34* 
(30.96%) 
 
350.65 ± 3.85* 
(31.20%) 
 
6 
 
364.13 ± 4.04 
(27.94%) 
 
219.78±1.41** 
(57.72%) 
 
216.10 ± 2.07* 
(57.72%) 
 
216.83 ± 1.85 
(57.45%) 
 
8 
 
321.31 ± 2.25 
(36.41%) 
 
151.93 ± 2.53 
(70.77%) 
 
152.56 ± 2.93 
(69.79%) 
 
155.01 ± 1.60** 
(69.58%) 
 
10 
 
250.43 ± 1.51 
(50.43%) 
 
94.58 ± 0.92** 
(81.80%) 
 
95.55 ± 0.95** 
(81.08%) 
 
93.63 ± 1.65** 
(81.62%) 
 
12 
 
182.29 ± 3.30 
(63.92%) 
 
35.41 ± 0.76** 
(93.18%) 
 
36.33 ± 1.34** 
(92.80%) 
 
36. 31 ± 0.90** 
(92.87%) 
 
14 
 
127.70 ± 1.60 
(74.72%) 
 
4.84 ± 0.17** 
(99.06%) 
 
5.29 ± 0.18** 
(98.95%) 
 
5.07 ± 0.28** 
(99.01%) 
 
16 
 
82.82 ± 1.27 
(83.61%) 
 
00 
(100%) 
 
00 
(100%) 
 
00 
(100%) 
 
Results are expressed as mean  SEM from four rats; *p < 0.001, **p <0.0001 vs. 
standard, one way ANOVA followed by Dunnet‟s t- test. 
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Graph 1: Effect of Dipteracanthus patulus leaf extracts on Aspirin induced ulcer 
model. 
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Graph 2: Effect of Dipteracanthus patulus leaf extracts on Ethanol induced ulcer 
model. 
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Graph 3: Effect of Dipteracanthus patulus leaf extracts on Excision wound model. 
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Chapter 6 
DISCUSSION 
 
Worldwide, there is a progressive tendency in favor of traditional and integrative 
health sciences both in research and clinical practice. Similarly both the chloroform, 
ethanolic extracts were evaluated for their anti-ulcer activity in aspirin and ethanol 
induced ulcer model in male Wistar rats.  Numerous factors are concerned in the 
ulcerogenesis and gastric mucosal damage induced by different models active in the 
present study relating, mucosal damage induced by non-steroidal anti-inflammatory 
drugs and excessive of free radical production. The extracts of the Dipteracanthus 
patulus has significantly protected the gastric mucosa against ethanol challenge as 
shown by reduced values of ulcer index as compared to control group signifying its 
potent cytoprotective effect. It is recommended that Dipteracanthus patulus extracts can 
suppress gastric damage induced by aggressive factors. It is commonly accepted that 
gastric ulcers result from an imbalance between aggressive factors then the keep the 
mucosal honesty through endogenous protection mechanisms. The excess gastric acid 
formation through prostaglandin (PG) increases in mucosal resistance as well as a 
decrease in aggressive factors, mainly acid and pepsin in the stomach. Inhibitions of PG 
synthesis by aspirin concur with the earlier stages of damage to the cell membrane of 
mucosal, parietal and endothelial cells of the stomach region.  
 Flavanoids are among the cytoprotective materials for which anti-ulcerogenic 
efficacy has been widely established. The preliminary phytochemical studies revealed 
that the presence of flavonoids in ethanolic extract of Dipteracanthus patulus. 
Consequently the possible mechanism of antiulcer action of Dipteracanthus Paulus may 
be due to its flavonoid content. In this study, we observed that Dipteracanthus patulus 
provides significant anti-ulcer activity against gastric ulcers in rats. Both of the extracts 
produced a significant (p<0.001) anti-ulcer activity. The significant increase in the 
antiulcer activity of Dipteracanthus patulus (Jacq) can be credited to the presence of 
flavanoids, alkaloids, tannins, saponins, glycosides, and steroids. It is suggested that 
these active compounds would be able to stimulate mucus, bicarbonate and the 
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prostaglandin secretion and counteract with the deteriorating effects of reactive oxidants 
in gastrointestinal lumen.[42] 
 
In NSAIDs-induced gastric ulcer model, the ulcers were induced in rats by the 
administration of Aspirin (500mg/ kg p.o). There will be eradication of the prostaglandins 
from the stomach mucosal region, which may cause ulceration, such as the 
prostaglandins need the major role in the gastric mucosa production. Hence, the 
purging of prostaglandins it reduces the protective mucosal secretion and increases 
acid secretion, thereby leading to ulceration in the stomach. In the present study, in 
gastric ulcer model induced by Aspirin (500mg/kg p.o) in rats the values of ulcer index 
were reduced in the treated group by D. patulus  ethanol extract 100mg/kg (3.05±0.12) 
and chloroform extract 100mg/kg (3.44±0.20) there was a significant reduction in the 
ulcer index (**P<0.0001) as standard compared to control group.[43] 
Ethanol-induced  ulcers  major  in  the  glandular  part  of  stomach was reported  
to stimulate the formation of leukotriene C4 (LTC4),mast cell secretory products, and re
active oxygen species resulting in the damage of rat gastric mucosa. In ethanol model, 
ulcers are caused due to perturbations of superficial epithelial cells,  notably  the  
mucosal  mast  cells  leading  to  the  release  of  the  vasoactive  mediators  as well as  
histamine,  therefore  producing  damage  to  gastric mucosa.  Mucosal  blood  flow  
has been attributed to be an important factor in the damage caused by alcohol and is  
modulated  by  prostaglandin. 
In the present study, in gastric ulcer model induced by Ethanol (1ml/kg p.o) in 
rats the values of ulcer index were reduced in the treated group D. patulus ethanolic 
extract 100 mg/kg (2.72±0.09) and chloroform extract 100mg/kg (2.97±0.20), there was 
a significant reduction in the ulcer index (**P<0.0001) as standard compared to control 
group.[44] 
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The repair of wounds involves different phases including contraction, formation of 
granulation tissue. The biological response regulating the body is own cellular defense 
mechanisms contributes to the wound and its repair. Topical application of D. patulus  
leaf ethanol and chloroform extract 20 %w/w ointment at wound site in excision wound 
healing model produced significant (**p <0.0001) wound healing activity. Treated 
excision wounds showed an increased rate of contraction, leading to closer healing as 
confirmed by the increased healed area when compared to the control group. Wound 
healing is a process by which a damaged tissue is restored as closely as possible to its 
normal state.[45] 
In Chorioallantoic membrane Assay model, Angiogenesis is vital in normal 
processes of the development of blood vessel of embryo, formation of corpus luteum 
and wound healing.[46] 
 Angiogenesis during wound repair helps the two fold function of providing the 
nutrients required by the healing tissue and contributing to structural repair through the 
formation of granulation tissue.[47] 
 D. patulus both extract stimulated angiogenesis as proved by CAM model 
showed a faster wound contraction. By comparing both the extracts, ethanolic extract 
show better activity than the chloroform extract. 
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Chapter 7 
 CONCLUSION 
  
In the conclusion, the Chloroform and ethanolic extract of Dipteracanthus patulus 
leaf that potentiated the anti-ulcer activity and wound healing activity. Both extract could 
be mainly due to the modulation of defensive factors through an development of 
gastrointestinal cytoprotection and partly due to suppression of gastric juice. Further 
Dipteracanthus patulus leaf extracts was found to possess wound healing activity on 
different phases of wound healing, including wound contraction and angiogenesis.   In 
this present study, used parameters on exposure to Aspirin and Ethanol induced ulcer 
model in rats and Excision wound model in rats and chorioallantoic membrane assay. 
The results obtained from these experimental models clearly confirmed the ethanolic 
and chloroform extract of Dipteracanthus patulus Leaf possessed Anti-ulcer activity and 
wound healing activity. 
Therefore further studies will be focused on the preliminary phytochemical 
studies responsible for the observed active constituents have to be isolated and 
identified. 
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Chapter 8 
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